Subscribe to Newsletter
Business & Profession Professional Development

This Month in Business

  • The FDA approves Alimera’s Iluvien (fluocinolone acetonide intravitreal implant) for the treatment of diabetic macular edema (DME) in patients previously treated with corticosteroids who did not have a significant increase in IOP.

  • Allergan’s Ozurdex (dexamethasone intravitreal implant) has had its DME indication expanded by the FDA. Formerly approved for the treatment of DME in pseudophakic adult patients or patients who were scheduled for cataract surgery, Ozurdex is now approved for the general patient population being treated for DME.

  • Allergan continues to resist Valeant’s US$54 billion takeover offer. It was in talks to buy specialist pharmaceutical company, Salix, for US$11 billion, wiping out Allergan’s net cash proportion that was so attractive to Valeant, but these talks have ended for now.

  • Oculentis is suing Lenstec for infringement of its UK patent for an IOL implant with an enhanced optical blending zone. It is alleged that Lenstec infringed the patent by importing and selling SBL-3 dual-topic IOLs. Oculentis is seeking an injunction against the company, as well as damages and control of the offending products.
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as a deputy editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: